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Oncogenes such as K-ras mediate cellular and metabolic transformation during tumorigenesis.
To analyze K-Ras-dependent metabolic alterations, we employed
13C metabolic ﬂux analysis (MFA),
non-targeted tracer fate detection (NTFD) of
15N-labeled glutamine, and transcriptomic proﬁling in
mouse ﬁbroblast and human carcinoma cell lines. Stable isotope-labeled glucose and glutamine
tracers and computational determination of intracellular ﬂuxes indicated that cells expressing
oncogenic K-Ras exhibited enhanced glycolytic activity, decreased oxidative ﬂux through the
tricarboxylic acid (TCA) cycle, and increased utilization of glutamine for anabolic synthesis.
Surprisingly, a non-canonical labeling of TCA cycle-associated metabolites was detected in both
transformed cell lines. Transcriptional proﬁling detected elevated expression of several genes
associated with glycolysis, glutamine metabolism, and nucleotide biosynthesis upon transforma-
tion with oncogenic K-Ras. Chemical perturbation of enzymes along these pathways further
supports the decoupling of glycolysis and TCA metabolism, with glutamine supplying increased
carbon to drive the TCA cycle. These results provide evidence for a role of oncogenic K-Ras in the
metabolic reprogramming of cancer cells.
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Introduction
Several decades ago Otto Warburg ﬁrst described that tumors
exhibit glycolytic metabolism with a reduced rate of oxidative
phosphorylation, despite the availability of adequate oxygen.
This phenomenon, known as the ‘Warburg effect,’ has been
proposed to be a key driver of tumor progression (Warburg,
1956). Since then, several researchers have observed altered
glucose metabolism associated with a high rate of lactate
secretion in cancer cells and tumor tissues (Sauer et al, 1982;
Steinberg et al, 1992). Furthermore, aerobic glycolysis
represents a robust hallmark of cancer that is employed for
tumor detection by positron emission tomography analysis
with the 2-[18F]ﬂuoro-2-deoxy-D-glucose tracer (Laing et al,
2009). However, we and others have recently provided
evidence on the important anabolic role of glutamine in tumor
cell proliferation (DeBerardinis et al, 2007; Yuneva et al, 2007;
Gaglio et al, 2009). Indeed, by using different experimental
approaches, it has been shown that glycolytic cancer cells
consume more glutamine as compared with their normal
counterparts to synthesize proteins, nucleotides and fatty
acids and produce energy (Kovacevic and McGivan, 1983;
Baggetto, 1992; DeBerardinis et al, 2007).
Several reports suggest that both nutrient uptake changes and
metabolic alterations are under direct control of ras or myc
oncogenes (Chiaradonna et al, 2006b; Wise et al, 2008; Vander
Heiden et al, 2009). In particular, oncogenic Ras proteins,
identiﬁed in 25% of human cancers (Bos, 1989), correlate with
metabolic alterations, including increased glucose and
glutamine consumption, lactic acid accumulation, altered
expression of mitochondrial genes, increased reactive oxygen
species (ROS) production and reduced mitochondrial activity
(Bos,1989;Vizanetal,2005;Chiaradonnaetal,2006a;Yunetal,
2009; Weinberg et al, 2010). A result of this metabolic
reprogramming is the dependence of K-Ras transformed cells
on glucose and glutamine availability, since their withdrawal
induces apoptosis and cell-cycle arrest, respectively (Rama-
nathan et al, 2005; Telang et al, 2006; Yun et al, 2009). However,
the precise metabolic effects downstream of oncogenic Ras
signaling in cancer cells have not been completely elucidated.
Dueto theinterconnected natureofmetabolicpathwaysand
the pleiotropic effects mediated by oncogenic signals, a
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suchtransformingevents.Todate,mostlarge-scaleanalysesof
tumor cells have employed microarray technology that
provides a robust means of analyzing transcriptional mod-
iﬁcations associated with physio/pathological changes (Ross
et al, 2000; Scherf et al, 2000). However, various levels of post-
transcriptional controls may not be captured by these analyses
(Mata et al, 2005; Metallo and Vander Heiden, 2010), and new
approaches are now emerging to increase our knowledge
about cancer cell physiology (Liotta and Petricoin, 2000;
Laubenbacher et al, 2009; Kreeger and Lauffenburger, 2010).
Metabolomic techniques offer a more direct means of
studying metabolism at the systems level. Measuring metabo-
liteconcentrations,indeed,representsasensitiveapproachthat
generates detailed ‘snapshots’ of biological processes (Hiller
et al, 2009). Nevertheless, metabolic routes are best character-
ized by the measurement of ﬂuxes, which describe the actual
functionality of a given enzyme or pathway (Stephanopoulos
andVallino,1991;Sauer,2006).Tothisend,isotopictracersand
computational algorithms enablethe quantitative estimation of
intracellular ﬂuxes and associated conﬁdence intervals for a
given system (Metallo et al, 2009; Hiller et al, 2010), and such
methodsarenoweffectivelyappliedtomammaliancells(Vizan
et al, 2005; Munger et al, 2008).
Therefore, to better understand the regulation of cancer cell
metabolism and to identify key metabolic routes altered in
K-Ras transformed cells, we have applied a systems-level
approach based on the combined application of metabolic
and transcriptional analyses. We have monitored the ﬂux of
13C-labeled glucose and glutamine as well as [a
15N]glutamine
into downstream metabolites in normal and transformed cells
and performed a detailed comparison with the transcriptional
proﬁles obtained from the same cell lines. Herein, we show
that K-ras oncogene expression enhances glucose uptake but
decreases its utilization in the tricarboxylic acid (TCA) cycle
and associated anabolic pathways. Furthermore, we showthat
while K-Ras transformation decreases overall ﬂux through the
TCA cycle, it increases utilization of the carbon backbone and
amino-nitrogen moieties of glutamine either through TCA
cycle or transamination activities in order to sustain biosyn-
thetic reactions, including amino-acid, nucleotide and glu-
tathione synthesis. Finally, we present evidence describing the
dependence of K-Ras on glutamine metabolism, as inhibition
of key enzymes along this pathway speciﬁcally compromises
the proliferation of transformed cells.
Results
K-Ras transformation enhances glycolytic ﬂux
and decreases oxidative TCA cycle ﬂux in
mouse ﬁbroblasts
We have previously shown that transformed NIH3T3 mouse
ﬁbroblasts expressing an oncogenic K-Ras protein (G12V)
(Shih et al, 1981; Pulciani et al, 1982; Bossu et al, 2000) exhibit
elevated sensitivity to glucose availability, reduced mitochon-
drial function linked to a decrease of Complex I activity and
protein level, and reduced proliferation in response to glucose,
glutamine or galactose shortage as compared with immorta-
lized NIH3T3 mouse ﬁbroblasts (Chiaradonna et al, 2005,
2006a; Gaglio et al, 2009;Baraccaet al, 2010). NIH3T3cells are
a geneticallywell-characterizedimmortalized cell line that has
longbeen established as a model of ‘normal’ cells for the study
of cell transformation, as these cells undergo contact inhibi-
tion, exhibit no growth in soft agar, and do not form tumors in
immunocompromised mice, in contrast to isogenic trans-
formed lines (Bossu et al, 2000).
Therefore, we performed basic metabolic analyses to
compare NIH3T3 cells (normal, N) and NIH3T3 K-Ras
(transformed, T) 54h (T54) after plating. This time point
was chosen since it corresponds to the time in which the two
cell lines begin to show a different proliferative ability
(Chiaradonna et al, 2006b). As shown in Figure 1A, cell-
speciﬁc glucose (Glc) and glutamine (Gln) consumption as
well as lactate (Lac) and glutamate (Glu) secretion were
measured. Signiﬁcant increases in Glc uptake and Lac
production in T cells were observed (Figure 1A), consistent
with other reports linking ras mutations to aerobic glycolysis
(Elstrom et al, 2004; Vizan et al, 2005). Although previous
studies have shown an increase of Gln uptake in other kinds
of cancer cell lines (Yuneva et al, 2007; Wise et al, 2008;
Gao et al, 2009), we did not detect any signiﬁcant changes in
Gln uptake and Glu secretion between the two cell lines. To
further deﬁne N- and T-cell metabolism, we have determined
the relative abundance of various intracellular amino and
organic acids by performing a targeted metabolomic analysis
(Figure 1B). Notably, metabolites associated with glycolysis
and biosynthetic processes were present in larger quantities
in T cells, including pyruvate (Pyr), Lac, citrate (Cit), and
aspartate (Asp). On the other hand, TCA cycle intermediates
such as a-ketoglutarate (AKG), succinate (Suc), and
fumarate (Fum), which arise primarily from oxidative
metabolism, were less abundant in T cells as compared
with N cells.
Isotopic tracers provide an effective means of determining
the relative contribution of a substrate to a particular
metabolic pathway, and mass spectrometry enables quantiﬁ-
cation of the relative abundance of molecules with different
numbers of isotopic label in each metabolite pool (i.e., M0,
M1, M2, y where M2 abundance includes all molecules with
two
13C-labeled atoms). For instance, uniformly labeled Glc
([U-
13C6]glucose) is converted to M3 Pyr (with three
13C
atoms) and subsequently M2 Cit through the combined action
of pyruvate dehydrogenase and citrate synthase. In the same
way, M2 Cit, progressing along the TCA cycle, generates M2
AKG and Glu by TCA cycle-related reactions (i.e., transamina-
tion and reductive amination; Supplementary Figure S1). We
cultured N and T cells in the presence of
13C-labeled glucose
and quantiﬁed the mass isotopomer distribution (MID)
of Cit and Glu via gas chromatography/mass spectrometry
(GC/MS). These data indicated that T cells oxidize less Glc
carbon to Cit and Glu, presumably diverting more Pyr to Lac,
as evidenced by the signiﬁcant decreases in M2 labeling
observed in these metabolites (Figure 1C).
Consistent with the observation of decreased Glc oxidation,
parallel [U-
13C5]glutamine labeling experiments indicated that
Gln carbon utilization for metabolic intermediate synthesis
(e.g. Asp) was increased in Tcells. We speciﬁcally observed a
relative increase in M3 and M4 Asp abundance (Figure 1D),
which are generated from M5 AKG downstream of reductive
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oxoglutarate dehydrogenase, respectively (Supplementary
Figure S2). These results support the notion that Gln entering
the TCAcycle of Tcells may follow both the canonical forward
oxidative reaction and a reductive carboxylation (Yoo et al,
2008). Moreover, given the signiﬁcant role of Asp in amino-
acid and nucleotide synthesis, these results suggest that Tcells
are strongly dependent on Gln carbon for biosynthesis
(Weinberg et al, 2010).
Mass isotopomer data alone provides a somewhat limited
view of cellular metabolism. To better characterize N- and
T-cell metabolism at the systems level, we integrated
our extracellular uptake and secretion results with MID data
obtained by culturing the cells with [U-
13C5]glutamine.
Using these data, we estimated intracellular ﬂuxes in each
celltypeusinganelementary metaboliteunit(EMU)-based
13C
metabolic ﬂux analysis (MFA) algorithm (Young et al, 2008).
Upon obtaining acceptable ﬁts, we performed a sensitivity
analysis to generate 95% conﬁdence intervals for each ﬂux in
the network (Antoniewicz et al, 2006; Antoniewicz et al,
2007).FluxresultsforNandTcellsarelistedinTableI,andthe
full dataset and model description are provided in Supple-
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13C5]glutamine. Error bars indicate s.e.m.
(n¼3). (E) Schematic representation of the metabolic routes involved in M3-M4 Asp labeling by using [U
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These data indicate that transformation induces a signiﬁcant
reorganization of central carbon metabolism. T cells reduce
ﬂux through the PDH complex by B50% (i.e., ﬂux values of
Pyr-AcCoAmitþCO2). Furthermore, net ﬂuxes throughout
the TCA cycle were decreased by the same amount. Each of
these changes was highly signiﬁcant, as evidenced by the lack
of overlap in conﬁdence intervals between the two cell types.
Although most exchange ﬂuxes in reversible reactions of the
TCAcyclecould not be accuratelydetermined, we observed no
signiﬁcant change in reductive ﬂux through IDH or malic
enzyme. Consistent changes in metabolic ﬂuxes were
observed when performing MFAusing labeling data from cells
cultured with
13C-glucose (see Supplementary Information for
detailed results), though the observability of some ﬂuxes
(e.g. IDH exchange ﬂux) was signiﬁcantly decreased when
using these tracers. These ﬁndings provide evidence that
transformationcausescellstodecoupleglycolysisandtheTCA
cycle,withanoveralldecreaseinactivityofoxidativereactions
within the TCA cycle.
Transcriptional proﬁling of N and T ﬁbroblasts is
largely coherent with metabolic ﬂux analysis
Various reports have indicated that oncogenes alter the
expression of genes encoding metabolic enzymes (Mathupala
et al, 1997; Zhong et al, 1999). To identify oncogenic
K-Ras-dependent transcriptional effects, we performed micro-
array transcriptional proﬁling of N and Tcells grown as above
for 48 and 72h.
Table I Experimentally determined ﬂuxes and 95% conﬁdence intervals estimated from MFA model using [U-
13C5]glutamine as a tracer
Reaction Normal Transformed T/N
Flux Conﬁdence interval Flux Conﬁdence interval
Glycolysis
Glucext-G6P 65.5 61.2, 69.9 83.1 77.6, 88.6 U
G6P-F6P 62.5 58.2, 66.9 82.1 77.6, 87.6 U
G6P2F6P 4.1 0.0, Inf 18.6 0.0, Inf ND
F6P-DHAP+GAP 64.2 59.9, 68.5 82.4 76.9, 88.0 U
DHAP-GAP 64.2 59.9, 68.5 82.4 76.9, 88.0 U
DHAP2GAP 36.7 0.0, Inf 13.1 0.0, Inf ND
GAP-3PG 129.2 120.6, 137.9 165 154.0, 176.1 U
GAP23PG 0 0.0, Inf 0 0.0, Inf ND
3PG-Pyr 129.2 120.6, 137.9 165 154.0, 176.1 U
Pyr-Lac 114.9 105.9, 123.4 158.1 146.9, 169.2 U
Pyr2Lac 300.5 0.0, Inf 9.2 0.0, Inf ND
Lac-Lacext 114.9 105.9, 123.4 158.1 146.9, 169.2 U
Pentose phosphate pathway
6PG-P5P+CO2 3.00 2.71, 3.29 1.00 0.90, 1.10 D
P5P+P5P-S7P+GAP 0.83 0.73, 0.93 0.17 0.13, 0.20 D
S7P+GAP-F6P+E4P 0.83 0.73, 0.93 0.17 0.13, 0.20 D
P5P+E4P-F6P+GAP 0.83 0.73, 0.93 0.17 0.13, 0.20 D
TCA cycle
Pyrmit+CO2-OAA 0 0.0, 3.2 0 0.0, 1.9 NC
Mal-Pyrmit+CO2 1.8 0.9, 5.9 1.8 0.7, 4.7 NC
Mal2Pyrmit+CO2 2.8 0.0, 3.2 1.6 0.0, 1.9 NC
Pyrmit-AcCoAmit+CO2 16.1 13.5, 19.1 8.6 7.6, 9.6 D
AcCoAmit+OAA-Cit 16.1 13.5, 19.1 8.6 7.6, 9.6 D
Cit-AKG+CO2 10.1 9.1, 11.2 5.4 4.9, 6.0 D
Cit2AKG+CO2 3.3 2.7, 3.9 3.7 3.2, 4.2 NC
AKG-Suc+CO2 12.1 10.6, 13.7 7.4 6.1, 8.7 D
Suc-Fum 12.1 10.6, 13.7 7.4 6.1, 8.7 D
Suc2Fum 37.2 0.0, Inf 0 0.0, 1.5 ND
Fum-Mal 12.1 10.6, 13.7 7.4 6.1, 8.7 D
Fum2Mal 0 0.0, Inf 42250 1.5, Inf ND
Mal-OAA 10.3 6.7, 11.3 5.6 3.5, 6.1 D
Mal2OAA 36.2 0.0, Inf 57630 3.2, Inf ND
Pyr-Pyrmit 14 12.0, 17.0 7 6.0, 8.0 D
Pyr2Pyrmit 74 39.0, 133 276 87.0, 4566 U
Glutamine metabolism
Glnext-Gln 20 19.0, 22.0 16 15.0, 17.0 D
Gln-Glu 20 19.0, 21.0 16 15.0, 17.0 D
Glu-Gluext 18 16.0, 19.0 14 12.0, 15.0 D
Glu-AKG 2 1.0, 3.0 2 1.0, 3.0 NC
Glu2AKG 168 115, 341 202 106, 1895 U
Pyrmit+Glu-Ala+AKG 0.15 0.13, 0.16 0.15 0.14, 0.17 NC
OAA+Glu-Asp+AKG 0.18 0.16, 0.20 0.18 0.16, 0.20 NC
Detailed description, assumptions,complete results,and data areavailable in Supplementary information. Net ﬂux: (uF uR)( -) and Exchange ﬂux: min (uF,uR)( 2).
Somescalingandundeterminedexchangeﬂuxes(i.e.,conﬁdenceintervalsofinﬁnity,Inf)areomittedforbrevity.Comparisonofﬂuxes(TransformedversusNormal)is
described as U¼up, D¼down, NC¼no change, and ND¼no detectable. Fluxes are listed  10
14 mol/(cell h).
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Figure S5, indicate that several genes of the investment phase
of glycolysis (Hk1 and Pfkp) as well as Pfkfb 2, 3 and 4, which
through the regulation of fructose-2,6-biphosphate level
allosterically control 6-phosphofructo-1-kinase, were consis-
tently expressed at lower levels in Tcells as compared with N
cells (Supplementary Figure S5A) (green color). In addition,
ﬁve genes encoding glycolytic enzymes (Gpi1, Pfkl, Pfkm,
AldoA and Tpi1) were highlyexpressed, particularlyat 48h, in
T cells as compared with N cells (red color) (Supplementary
FigureS5A). Moreover,a highexpression forgenesinvolvedin
the pay-off phase of glycolysis, where ATP is generated, was
observed. Indeed, almost all the genes of this phase, at both
time points 48 and 72h, were expressed at a higher level in
T cells as compared with N ones (Gapdh, Pgk1, Eno1, Eno2,
Pkm2, Ldha and Ldhb).
Consistent with the reduction of TCA ﬂux that we observed,
three genes encoding kinase that inhibit the PDH enzyme
complex activity (Pdk1, Pdk3, and Pdk4) were signiﬁcantly
expressed in Tcells (Supplementary Figure S5B). In addition,
expression of Ogdh, which encodes one subunit of the
oxoglutarate dehydrogenase complex, another key control
point in the TCA cycle, was decreased in Tcells (Supplemen-
tary Figure S5B). On the contrary, few genes encoding for
positive regulators of TCAcycle, as Aco2, Sucla2 and Sucgl2,a s
well as Idh2, which is able to catalyze the reductive
carboxylation of AKG, were expressed at higher levels in
T cells throughout the time window of the analysis as
compared with N ones (Supplementary Figure S5B). Taken
together, these results indicate that numerous genes regulated
by oncogenic K-Ras may drive the observed metabolic
reprogramming, although we cannot exclude the possibility
that other mechanisms (e.g., post-translational modiﬁcations,
massaction, and allosteric enzymeregulation) alsoparticipate
in the observed metabolic alterations of transformed cells.
Transcriptional analysis of glutamine entry
into TCA cycle
Previous experiments (Figure1) indicated that Gln contributes
to precursors of cellular biomass (e.g., aspartate) to a greater
extent in Tcells ascomparedwith Ncells,despite theobserved
small decrease in uptake. These ﬁndings are consistent with
other reports describing Myc-driven increases of Gln usage
through glutaminolysis, mediated in part via expression of
genes involved in Gln uptake and metabolism (Wise et al,
2008; Gao et al, 2009). To investigate this feature, we have
analyzed the expression of genes encoding enzymes involved
in Gln uptake and metabolism, with particular attention
to those involved in metabolic pathways able to generate Asp.
As shown in Figure 1E, Asp can be produced from Gln both in
cytoplasm and in mitochondria through AKG by oxidative
decarboxylation and reductive carboxylation. Gln enters
into the cells by high-afﬁnity glutamine importer Slc1a5 and
is metabolized to Glu by glutaminase (Gls) (Figure 1E).
Subsequently, Glu may be converted to AKG, either via
transaminase activity of cytoplasmic and mitochondrial
aspartate and alanine aminotransferases (Got1 and Got2 and
Gpt1 and Gpt2, respectively) or via glutamate dehydrogenase-
dependent oxidative deamination (Glud1) (Figure 1E). As
shown in Figure 1F, Slc1a5, Gls1, and Glud1 were consistently
expressed at lower levels in Tcells (about two-fold) relative to
N cells. On the contrary, Got1 and 2, showed an opposite
behavior, with both genes slightly upregulated in T cells
compared with N cells. These transcriptional changes
may partially justify the slight reduction in Gln uptake
(e.g., downregulation of Slc1a5 in transformed cells) shown
in Figure 1A and suggest, by analysis of the metabolic routes
depicted in Figure 1E, a relevant role of AKG for the generation
of labeled M4 Asp through oxidative metabolism (see also
transcriptional data in Figure 1F and Supplementary Figure
S5). In addition, in T cells, higher expression of Idh2
(Supplementary Figure S5) and in particular of Acly, whose
level was at least two-fold higher than N cells (Figure 1F), is
coherent with the increased M3 Asp labeling previously
shown. However, while transcriptional data are for the most
part consistent with the reduction of glutamine uptake and its
use for biosynthesis, not all metabolic ﬂuxes are expected to
be only regulated at the transcriptional level.
Transformed cells increase their use of glutamine
nitrogen for biosynthetic processes
To further investigate the role of Gln in cellular biosynthesis,
we performed a non-targeted tracer fate detection (NTFD)
analysis using amino-labeled glutamine ([a-
15N]glutamine) to
identify and quantify metabolites containing glutamine-
derived nitrogen. This method enables the detection and
quantiﬁcation of label in all observable metabolites down-
stream of the tracer substrate (Hiller et al, 2010). Cells require
nitrogen atoms to build molecules such as nucleotides, amino
acids,aminosugarswith GlnandGlurepresentingtheprimary
cellular reservoir of nitrogen. The amino nitrogen of Gln is
retained on Glu and used as a nitrogen donor in transaminase
reactions. As expected, the NTFD algorithm identiﬁed many
amino acids and associated compounds that were highly
labeled from [a-
15N]glutamine tracer, including Glu, Ala, Asp,
and 5-oxoproline (5-oxo) (Figure 2A). With the exception of
Asp, each of these metabolites was more signiﬁcantly labeled
in Tcells as compared with N cells. In addition, we observed
that M1 and M2 labeling on the nucleobase adenine, generated
from [a-
15N]glutamine-derived nitrogen atoms from Asp, was
over 2–3-fold higher in Tcells compared with N control cells
(Figure 2B).
Transcriptional data support results from NTFD analysis
with [a-
15N]glutamine. Absolute gene expression values of N
and T cells and their ratio (T/N ratio) as well, shown in
Figure 2C, Supplementary Table S1, highlight the elevated
expression of genes closely related to Gln utilization in Tcells.
In particular, the expression of genes involved in glutathione
metabolism (e.g., Gss, Gclm), hexosamine metabolism
(e.g., Gfpt1), and nucleotide biosynthesis (e.g., Cad, Adss,
and Adsl) was increased in T cells as compared with N cells.
Such transcriptional changes suggest increased activity of
glutathione pathway and the enhancement of nucleotide
synthesis, as indicated respectively by downstreammetabolite
5-oxo labeling (Figure 2A) and M1 and M2 labeling on the
nucleobase adenine (Figure 2B). In this regard, detailed
K-Ras decouples glucose and glutamine metabolism
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(Figure 2D) have indicated a more sustained expression in T
cells as compared with N cells. Altogether, these ﬁndings
further suggest the main role of Gln in supporting anabolic
processes of Tcells as compared with N cells.
K-Ras transformed human cells show metabolic
alterations similar to those observed in mouse
transformed cells
To test whether human cancer cells exhibit similar metabolic
alterations to the previously described mouse model of
transformation, we next sought to expand our metabolic and
transcriptional analyses to the MDA-MB-231 human breast
carcinoma cell line, which express an activated K-Ras protein
(G13D). To assess the glycolytic phenotype of MDA-MB-231
cells, asynchronous cells grown in high and low Glc (25 and
1mM, respectively), were followed in a time course of 96h.
AsshowninFigure3A,MDA-MB-231cellsgrownin25mMGlc
continued to proliferate and reached a much higher cell
density compared with those in 1mM Glc. In fact, in low Glc
cells completely lost their proliferation ability and showed
evident signs of cell death at 48h, as revealed by proliferation
curves (Figure 3A) and by morphological analysis (data not
shown). In addition, MDA-MB-231 cells are dependent upon
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signiﬁcantly limited growth compared with normal culture
(Figure 3A). Since the effects of Glc and Gln shortage on cell
viability and proliferation of MDA-MB-231 cells were very
similar to those observed in the mouse model of K-Ras-
dependent transformation, we analyzed the metabolic pheno-
typeof thesehuman cancercells ingreaterdetail.Extracellular
ﬂux quantiﬁcations indicated that MDA-MB-231 cells convert
Glc to Lac at approximately stoichiometric levels (i.e., 2:1;
Figure 3B). Indeed GC/MS analysis of cells cultured with a 1:1
mixture of [1-
13C]glucose and [U-
13C6]glucose have demon-
strated that at least 90% of Lac was derived from Glc (i.e., M3
Lacabundancewasmeasured at44.6±0.1%). Comparedwith
murineNandTcells,MDA-MB-231cellsconsumemuchhigher
amounts of Glc relative to Gln (Figure 3C). However, direct
oxidativeconversionofGlnstillaccountedforasmuchas40%
of the Fum, Mal, and Asp pools in cells cultured with
[U-
13C5]glutamine (see M4 mass isotopomer abundances;
Figure 3D). Taken together, these data indicate that, much like
transformed mouse cells,MDA-MB-231 cells divert most Glc to
Lac and rely on Gln carbon for anaplerosis.
Using extracellular ﬂux data and MIDs obtained from MDA-
MB-231 cells cultured for 54h with [U-
13C5]glutamine, we
performed MFA to determine intracellular ﬂuxes throughout
central carbon metabolism. The results of this analysis
(Supplementary Figure S6; Supplementary Table S4) indicated
that, in a similar way to mouse T cells, MDA-MB-231 cells
exhibit high glycolytic ﬂux and signiﬁcantly lower TCA cycle
activity. This comparison is best demonstrated by plotting the
ratio of PDH ﬂux to Glc consumption (Figure 3E). While Pyr
oxidation ﬂux is B25% of Glc uptake in control N cells, cells
with oncogenic K-Ras exhibit a PDH ﬂux p10% of Glc
consumption. Therefore, oncogenic K-Ras consistently drives
the decoupling of central carbon metabolism, increasing the
glycolyticﬂuxtoLacanddecreasingoxidativeTCAﬂuxincells
with different genetic backgrounds (Figures 1 and 3).
Importantly, MDA-MB-231 cells carry a mutant p53 (Olivier
et al, 2002), whereas K-Ras-NIH3T3 cells have wild-type p53
(Wadhwa et al, 1999). Given the fact that recent literature
results have implicated the p53 tumor suppressor protein as a
regulator of mitochondrial respiration and the Warburg effect
(Matoba et al, 2006), we tested the effect of p53 status on
these metabolic changes to ensure our results were speciﬁc to
oncogenic K-Ras. Comparing p53
þ/þ wild-type (HCT116
p53
þ/þ) or a p53
 /  KO (HCT116 p53
 / ) colon carcinoma
cells, which express oncogenic K-Ras (Bunz et al, 1998), we
observed no signiﬁcant differences in proliferation under
nutrient deprivation (Supplementary Figure S7A and B) or
intracellular metabolite abundances (Supplementary Figure
S7C–F). These data indicate that oncogenic K-Ras, at least in
these cellular models, contributes to cancer-speciﬁc metabolic
changes in a way that is not dependent on the presence of
wild-type p53.
In order to analyze the relationship between our metabolic
analysis and transcriptional proﬁling, microarray datasets of
MDA-MB-231 cells and normal breast tissues were recovered
from publicly accessible gene expression proﬁle dataset (GEO
and CellMiner). Data were analyzed as previously described
(Balestrieri et al, 2009), and results indicated that several
glycolytic genes (i.e., Hk1, Pfkp, Eno1, and Ldha) were
expressed at a higher level in cancer cells as compared with
normal breast tissue (Supplementary Figure S8A), in agree-
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Differences in gene expression were also observed for several
TCA cycle genes (Supplementary Figure S8B).
These ﬁndings, collectively, suggest that oncogenic K-Ras
transformation induces cell-speciﬁc transcriptional programs
that have a role in the metabolic alterations we observed (i.e.,
increased glycolytic activity) and highlight the utility of
systems-level approaches. Figure 4 depicts a schematic view
of metabolism, indicating the changes we observed upon
K-Ras transformation using
13C MFA and transcriptional
proﬁling. In particular, it can be observed that both K-Ras
transformed mouse and human cells, as shown by previous
metabolic analyses, divert most part of consumed Glc to Lac
(Figure 4A, red arrows). Such a preferential metabolic ﬂux is
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signiﬁcant glycolytic genes in both cell lines (i.e., Adpgk,
Gadph, Pgk, Eno 1 and 2, Pkm2 and Ldha; Figure 4A, right
box). In addition, the reduced ﬂux of pyruvate entering into
mitochondria(Figure4A,greenarrow)andthederegulation of
several genes encoding TCAcycle enzymes (Figure 4A) in part
provide an explanation of the decreased TCA cycle ﬂux
observed in both transformed cells lines (Figure 4A, green
arrows). At the same time, our metabolic data indicate
that such a reduced TCA cycle ﬂux in transformed cells has
an important anabolic role and is essentially fueled by Gln, as
suggested by the identiﬁcation of labeled Asp, a product of
Gln-derived TCA cycle intermediates (Figure 4A). Further-
more, the important role of Gln in supporting anabolic
processes of cancer cells (Figure 4B, red arrows) is suggested
by the identiﬁcation of labeled metabolites containing
Gln-derived nitrogen and associated increases in the expres-
sion of genes involved in glutathione metabolism (Gclm, Gss,
and Ggta1), hexosamine metabolism (Gfpt1), and nucleotide
biosynthesis(Cad,Adss,andAdsl)(Figure4B).Takentogether,
these ﬁndings indicate a major alteration in cancer cell
metabolism with a decoupling between Glc and Gln fates.
Metabolic alterations are dependent upon
oncogenic K-Ras activation and glutamine
utilization
To directly assess the role of oncogenic K-Ras in the previously
described metabolic alterations of transformed cells,
we performed several metabolic analyses by taking advantage
of a cell line, NIH3T3-GEF-DN (reverted cells, R), stably
expressing a dominant-negative Guanine Exchange Factor
CDC25 (GEF-DN) that speciﬁcally attenuates oncogenic K-Ras
activation (Vanoni et al, 1999; Bossu et al, 2000). Notably, R
cells exhibit changes consistent with a regression of cellular
transformation, including Ras-GTP levels, morphology,
anchorage-independent growth, reduction of Ras-dependent
tumor formation in nude mice, glucose and glutamine
dependence and mitochondrial dysfunction to a phenotype
similar to that observed in N cells (Chiaradonna et al, 2006b;
Gaglio et al, 2009).
To compare the metabolic phenotype of R cells with N and T
cells, the intracellular concentration of Cit and Mal (Figure 5A
and B) or Glu and Asp (Figure 5C and D) was measured by
enzymatic assays in cells cultured for 54h in optimal growth
conditions (25mM Glcþ4mM Gln). Results indicated that
N and R cells contained similar abundances of these
metabolites, while T-cell metabolic abundances were similar
to those previously observed using GC/MS. To further detail
themetaboliccharacteristicsofRcellsascomparedwithNand
T cell lines and evaluate whether Gln utilization is a general
requirement for the proliferation of K-Ras transformed cells,
weperformedcellproliferationanalysesinmediumcontaining
low Glnþ each of two cell permeable glutamine products,
dimethyl aspartate (DMD) and dimethyl a-ketoglutarate
(DMK). As shown in Supplementary Figure S9, Gln shortage
caused a proliferation reduction only in T cells, which was
partially rescued by addition of DMD or DMK (Supplementary
Figure S9).
TofurthertestwhetherGlnmetabolisminducedinTcellswas
dependent on the K-ras oncogene, we treated N, T, and
R cell lines with aminooxyacetate (AOA), an inhibitor of
aminotransferase activity (Figure 5E) and epigallocatechin
gallate (EGCG), an inhibitor of glutamate dehydrogenase
(GDH) activity (Figure 5F). As shown in Figure 5E, only T-cell
proliferation was inhibited by AOA treatment (Figure 5E,
compare middle panel versus left panel:N cells and right panel:
R cells)and rescued by DMD addition andnot by DMKaddition
(Figure5E).Thesedatasuggestthataminotransferaseactivityis
necessary to sustain cancer cell growth and Gln-derived Asp is
an important anabolic precursor for cancer cell growth.
Analogous proliferation experiments were performed in N,
T, and R cell lines upon treatment with EGCG. As shown in
Figure 5F, the treatment induced cell death in all cell lines.
Nevertheless, the reduction of cell number was markedly
greaterin Tcells comparedwith that observedin N and R cells.
Importantly, addition of DMK completely rescued viability in
all the three cell lines (Figure 5F). Given the signiﬁcant level of
cell death observed in all cells at 24h, we investigated
the effects of EGCG on cell survival at earlier time points
(between 0 and 8h) to better understand the mechanism of
cytotoxicity. EGCG reduced viability in all three cell lines
in a time-dependent manner, with T cells being the most
sensitive to EGCG treatment (Figure 6A, light gray bars).
Interestingly, the antioxidant N-acetyl-L-cysteine (NAC)
protected only T cells from EGCG-mediated cytotoxicity
(Figure 6A), suggesting a speciﬁc role of ROS accumulation
for their cell death. To ascertain whether EGCG induced a
different type of cell death in Tcells as compared with N and R
cells, cells were treated for 8h with EGCG and stained with
Annexin V (AV) and propidium iodide (PI), indicators of late
apoptosis and of plasma membrane permeability, respectively.
Untreated cells exhibited an AV-negative/PI-negative pattern
showing viable cells (Figure 6B, upper panels), whereas N and
R cells treated with EGCG for 8h exhibited an AV-negative/PI-
positive pattern, showing a dead population with loss of
plasma membrane integrity, typical of necrosis (Figure 6B,
bottom panels). T cells treated with EGCG contained a
population of AV-positive/PI-positive pattern, showing a
typically apoptotic population with an increased AV signal.
These resultswereconﬁrmed also bycell morphologyanalysis
after EGCG treatment. While EGCG induced ﬂattened and
attached cell remnants in N and R cells (almost all PI-positive
cells), EGCG-treated Tcells were detached and rounded cells
(data not shown).
Given the fact that ATP depletion is more likely to induce
necrosis, while ROS accumulation is more typically associated
with apoptosis, we measured intracellular ATPand ROS levels
upon 3h of EGCG treatment in each cell line. As shown in
Figure 6C, EGCG caused a signiﬁcant decrease of intracellular
ATPlevelsinNandRcells,whichcouldnotberescuedbyNAC
treatment. On the contrary, ROS levels were high and almost
constant in T cells regardless of EGCG treatment, whereas N
and R cells experienced a decrease in ROS levels upon EGCG
treatment (Figure 6D). Absolute levels of intracellular ROS in
untreatedTcellsat3hwereabouttwo-foldhigherascompared
with N and R cells (e.g., N¼193.5; T¼317.2; R¼141.7), and
addition of NAC reduced ROS levels in all cells (Figure 6D).
Altogether, these ﬁndings suggest that GDH activity, through
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cell lines, and its inhibition may cause in N and R cells
an energy derangement followed by necrosis, due to ATP
depletion, and in T cells an antioxidant depletion that
ultimately may bring to apoptosis. In conclusion, these results
suggest a role of glutamine in endogenous antioxidant
production, for instance glutathione synthesis, further
conﬁrming the anabolic role of glutamine in Tcells.
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Figure 5 Relative metabolites concentrations in N, T, and R cell lines and effect of aminooxyacetate (AOA) and epigallocatechin gallate (EGCG) treatments on their
proliferation. Evaluation of Cit (A), Mal (B), Glu (C), and Asp (D) intracellular concentrations was carried out after 54h of grown in normal medium by using enzymatic
assays. Analysis of AOA (E) and EGCG (F) treatments on N, T, and R cell lines proliferation. Cells, seeded at density of 3000 cells/cm
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counted at indicated time points. Error bars indicate s.e.m. (n¼3).
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Cancer is a complex disease that arises from numerous
molecular changes on a various cellular pathways (Mazurek
et al, 1998; Hanahan and Weinberg, 2000). Among these
alterations is the reprogramming of metabolic pathways
associated with bioenergetics and cellular biosyntheses, and
metabolic interventions are now emerging as potential
therapeutic targets (Michelakis et al, 2010; Vander Heiden
et al, 2010; Wise and Thompson, 2010). In this paper, we used
13C MFA, NTFD analysis, and transcriptional proﬁling to
provide a comprehensive analysis of cancer cell metabolism
and of its regulation by the K-ras oncogene. The results,
summarized in Figure 7, highlight the reprogramming of
metabolic pathways that occurs upon introduction of mutant
forms of K-Ras. In cancer cells, most consumed Glc is diverted
to Lac (Figure 7, red arrows), while the oxidation of Pyr to
AcCoA via PDH is consistently decreased (Figure 7, green
arrows). This decrease results in a marked reduction of TCA
cycleﬂux(Figure7,greencirclearrow), presumablycausedby
expression of Pdk genes. It is intriguing to note that both
mouse and human transformed cells herein analyzed, present
a substantially lower mitochondrial Complex I activity
(Ishikawa et al, 2008; Baracca et al, 2010). Consistent with
suchadecreaseinglucoseutilizationthroughtheTCAcycle,in
cancer cells Gln becomes the more relevant source of both
carbon and nitrogen for cellular biosynthesis (Figure 7, black,
blue, and sky-blue arrows), through aminotransferase
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were treated as above described and collected at indicated time points. (D) Intracellular ROS levels were measured by using 5mM DCFH2-DA staining. The cells were
treated as above described and collected at indicated time points. Error bars indicate s.e.m. (n¼3).
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(Figure 7, black, blue, and sky-blue arrows).
In conclusion, in K-Ras transformed cells the decoupling
between Glc and Gln metabolism leads to an efﬁcient
utilization of both carbon and nitrogen from Gln into biomass
building blocks (amino acids and nucleotides) and glu-
tathione. Both, sustaining growth and the ability to quench
ROS production, may promote cancer cell proliferation and/or
survival.Thestrongdependenceoftransformedcellgrowthon
Gln availability is, therefore, not surprising (Gaglio et al, 2009;
Wang et al, 2010; Weinberg et al, 2010). Our analysis also
suggests that transcriptional changes contribute to the
observed metabolic reprogramming in mouse and human
transformed cells. In the future, detailed analyses of the
various enzymatic steps involved in the growth-sustaining
metabolism as well as genes regulating these reactions
may shed light on the molecular basis of transformation. In
addition, these results may enable the identiﬁcation of fragile
points in the metabolic network and more effective, targeted
cancer therapeutics.
Materials and methods
Cell culture
Mouse embryonic ﬁbroblast NIH3T3 cells (CRL-1658; American Type
Culture Collection) and a K-Ras transformed NIH3T3-derived cell line,
226.4.1 (Pulciani et al, 1985), were routinely grown in Dulbecco’s
modiﬁed Eagle’s medium containing 10% newborn calf serum, 4mM
L-glutamine, 100U/ml penicillin, and 100mg/ml streptomycin (nor-
mal growth medium) (all from Invitrogen, Carlsbad, CA, USA) at 371C
inahumidiﬁedatmosphereof5%CO2.TheNIH-GEF-DN(revertedcell
line), stably and constitutively expressing the dominant-negative
mutant Cdc25MmW1056E (GEF-DN; Bossu et al, 2000), was main-
tained in normal growth medium supplemented with 0.7mg/ml
geneticin (G418;Sigma-AldrichInc.,StLouis, MO,USA).MDA-MB-231
human breast carcinoma cell line, obtained from the European
Institute of Oncology (Milano, Italy), was grown in Dulbecco’s
modiﬁed Eagle’s medium containing 5% fetal bovine serum, 4mM
L-glutamine, 100U/ml penicillin, and 100mg/ml streptomycin
(normal growth medium) (all from Invitrogen, Carlsbad, CA, USA)
at 371C in a humidiﬁed atmosphere of 5% CO2. HCT116 p53
þ/þ and
HCT116 p53
 /  cells, obtained from the European Institute of
Oncology (Milano, Italy), were cultured with complete DMEM plus
10% FBS. Cells were passed using trypsin-EDTA (Invitrogen) and
maintained in culture for 48h before manipulation.
Cell proliferation analysis and cell treatments
Forlong-termstudies,cellswereplatedatthedensityof3000cells/cm
2
in complete growth medium. After 18h, the cells were washed twice
with phosphate-buffered saline (PBS) and incubated in a media with
different glucose concentrations (25 and 1mM glucose) or different
glutamine concentrations (4 and 0.5mM glutamine) (time 0).
When indicated, cells were treated with 100mMA O A( O-(Carbox-
ymethyl)hydroxylamine hemihydrochloride), or 20mM (-)-EGCG, or
2mM dimethyl 2-Oxoglutarate -DMK- or 1mM L-Aspartic acid
b-methyl ester hydrochloride -DMD- (Sigma-Aldrich Inc.). For short-
term studies, cells were plated and grown as above and then treated
with 20mM EGCG or 5mM NAC (Sigma-Aldrich Inc.). To measure cell
proliferation, harvested cells were counted by Burker chamber.
Microarray data collection
Microarray transcriptional proﬁles were extracted from two different
datasets. The mouse time course data were obtained from a
transcription proﬁles collection of NIH3T3 and NIH3T3 K-Ras mouse
ﬁbroblasts, generated in our laboratory, grown in 25mM gluco-
seþ4mM glutamine, along a time course of 72h. In particular, the
cells used for the time course transcription analysis, were collected
at 18h from the initial seeding, time corresponding to the change of
medium (indicated as T0) and at 24, 48 and 72h (NCBI GEO database
accession from GSM741354 to GSM741361 and from GSM741368 to
GSM741375ofNIH3T3andNIH3T3K-Ras,respectively).Foreachtime
points,labeledcRNAwasgeneratedbyusingtheAffymetrixOne-Cycle
Target Labeling and Control Reagent kit (Affymetrix Inc., Santa Clara,
CA, USA), following the manufacturer’s protocol and was hybridized
usingAffymetrixGenechips(MouseGenome4302.0Array)inorderto
determine the global gene expression patterns. Arrays were washed
and scanned on the Affymetrix Complete GeneChip
s Instrument
System and processed into CEL ﬁles.
Human raw expression data for U133A arrays were obtained from
publicly accessible gene expression proﬁle database GEO (http://
www.ncbi.nlm.nih.gov/geo/) or CellMiner (http://discover.nci.nih.
gov/cellminer/home.do). In particular, we used the transcription
proﬁles data of the human breast cancer cell line MDA-MB-231
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tissue (NCBI GEO accession GSM44683). Both mouse and human
transcriptional data were separately submitted on the same procedure
of normalization and ﬁltering of noise, in order to obtain a good degree
of comparison across the different experiments. Brieﬂy, the data ﬁles
(CEL ﬁles) were imported into GeneSpring GX 11.0.2 software (Agilent
Technologies Inc.), by using RMA method, were normalized and
summarized as probe-level intensity measurements (Irizarry et al,
2003).Inparticular,thealgorithmimplementedinGeneSpring,starting
from the perfect-match probe-level data of a set of arrays, performs the
background correction, the normalization and ﬁnally summarize the
resultsasasetofexpressionmeasuresforeachprobeset.Subsequently,
also ‘per-gene normalization’ was performed as described in Gene-
Spring’s manual. Altogether, these procedures permitted to obtain the
relative expression of each probe set in a log2 scale with the value 0 as
center. This scale of measurement was used for the heat maps showed
in the paper. From these two datasets (mouse and human) have been
identiﬁed and gathered the expression levels for genes encoding
proteins involved in glycolysis, TCA cycle and glutamine metabolism,
at 48 and 72h for mouse datasets and, at time indicated by the authors
for both human tissue and cell line samples. Total selected mouse and
human genes and their intensity expression levels have been reported
in Supplementary Dataset.
Metabolite extraction
For labeling experiments and GC/MS-based metabolomics, asynchro-
nous NIH3T3, NIH3T3 K-Ras, and MDA-MB-231 were plated at 3000
cells/cm
2 in 6-well plates with normal growth medium. In all, 18h
after seeding, cells were washed with PBS and incubated in different
DMEM (Sigma) plus 10% dialyzed serum supplemented with
unlabeled glucose or glutamine and either 4mM [U-
13C5]glutamine
or a 25mM 1:1 mixture of [U-
13C6]glucose and [1-
13C]glucose. After
54h, spent medium was collected and analyzed for glucose, lactate,
and glutamine consumption on a YSI7100 analyzer. Cells were quickly
rinsed with PBS to minimize spent medium carryover and quenched
with 0.4ml ice-cold methanol. An equal volume of water containing
1mgnorvalineinternalstandardwasadded,andcellswerecollectedby
scraping with a pipette tip. Two volumes of chloroform were added,
and the cells were vortexed at 41C for 30min. Samples were
centrifuged at 3000g for 10min, and the aqueous phase was collected
in a new tube and evaporated under airﬂow at room temperature.
Derivatization and GC/MS measurements
Dried polar metabolites were dissolved in 60ml of 2% methoxyamine
hydrochloride in pyridine (Pierce), sonicated for 30min, and held at
371C for 2h. After dissolution and reaction, 90ml MBTSTFAþ1%
TBDMCS (Pierce) was added and samples were incubated at 551C for
60min. GC/MS analysis was performed using an Agilent 6890 GC
equipped with a 30-m DB-35MS capillary column connected to an
Agilent 5975BMS operating under electron impact (EI) ionization at
70 eV, 1 ml of sample was injected in splitless mode at 2701C, using
helium as the carrier gas at a ﬂow rate of 1ml/min. The GC oven
temperature was held at 1001C for 3min and increased to 3001Ca t
3.51C/min for a total run time of B60min. The MS source and
quadrupole were held at 230 and 1501C, respectively, and the detector
wasoperatedinselectedionmonitoringmode.MIDswereobtainedfor
each measured metabolite and incorporated with extracellular ﬂux
measurements for ﬂux determination. For determination of relative
metabolite abundances, the integrated signal of all potentially labeled
ions for each metabolite fragment was normalized by the signal from
norvaline and the per well cell number (obtained by counting
surrogate plates).
Flux estimation
Intracellular ﬂuxes were estimated for a model reaction network by
minimizing the lack of ﬁt between actual and simulated ﬂux and
GC/MS measurements. The network contained simpliﬁed versions of
glycolysis, the PPP, anaplerotic reactions, the TCA cycle, and amino-
acid biosynthesis. Speciﬁc assumptions regarding the network and
metabolism that were made for the sake of the ﬂux analysis are listed
in Supplementary information. We additionally calculated 95%
conﬁdence intervals for each ﬂux using parameter continuation
(Antoniewicz et al, 2006). All ﬂux simulation, estimation, and
continuation in this study were conducted using Metran, a ﬂux
analysis tool built upon an EMU framework (Antoniewicz et al, 2007;
Yoo et al, 2008;Younget al,2008).Whenrequired,MIDswerecorrected
for natural isotope abundance using in house algorithms adapted from
Fernandez etal (1996). Simulated and measured MIDs for MFAof N and
T cells are presented in Supplementary Figures S2 and S3 ([U-
13C5]
glutamine) or S10 and S11 ([U-
13C6]glucoseþ[1-
13C]glucose). Data
for MDA-MB-231 cell MFA ([U-
13C5]glutamine) are presented in
Supplementary Figure S6.
Non-targeted tracer fate detection
The NTFD analysis was performed to determine the metabolic fate of
the a-amine nitrogen atom of glutamine (Hiller et al, 2010). Cells were
incubated for 54h as described above, but instead of unlabeled
glutamine, a 1:1 mixture of unlabeled and [a-
15N]glutamine (Cam-
bridge Isotope Laboratories) was employed for each growth condition.
Since it is a requirement ofNTFD, additionalcells were cultivatedwith
completely unlabeled glutamine as reference. Both cultivations were
performed in triplicate and intracellular metabolites were extracted
and measured as described above. The raw GC/MS data were used as
inputfortheNTFDsoftwareandalldetectedlabeledcompoundsforall
growth conditions were matched using algorithms of the Metabolite
Detector software package (Hiller et al, 2009). Finally, the NIST
reference library was employed for compound identiﬁcation (Babush-
ok et al, 2007).
Metabolite assay
For enzymatic assay quantitation of aspartate, citrate, malate, and
glutamate, asynchronous NIH3T3, NIH3T3 K-Ras, and NIH-GEF-DN
were platedat 3000cells/cm
2 withnormalgrowthmedium.In all, 18h
after seeding, cells were washed with PBS and incubated in medium
with 25mM glucose and 4mM glutamine. After 54h, the cells were
washed twice with PBS cold and collected using trypsin-EDTA
(Invitrogen). The cells were counted and 500000 cell aliquots were
rapidly homogenized with appropriate assay buffer on ice. The
samples were centrifuged at 15000g for 10min to remove cell debris
and deproteinized using a perchloric acid/KOH protocol (BioVision).
The samples were added into triplicate wells of a 96-well plate and the
volume was brought to 50ml with assay buffer. The samples were
incubated for 30min at room temperature or at 371C, protected from
light. Then, OD was measured in a microplate reader.
Intracellular ATP quantiﬁcation
Intracellular ATP levels were measured using CellTiter Glo
s luciferin-
luciferase assay (Promega) according to the manufacturer’s protocol.
Inparticular,100mlofcellsuspensioncontaining10
4cellswasaddedto
an equal volume of CellTiter Glo Reagent in a single well of 96-well
plate. The emitted luminescence was collected after incubation at the
wavelength of 560nm using Cary Eclipse spectroﬂuorimeter (Varian)
and the luminescence values were converted in ATP quantities after
the setting of a calibration curve.
ROS levels measurement
Detection of ROS levels was carried out through ﬂow cytometric
analyses using a FACScan ﬂow cytometer (Becton-Dickinson) with
CellQuest software (BD Biosciences). ROS levels were measured
through staining plated cells with 5mM dichloro-dihydro-ﬂuoresceine-
diacetate (DCFH2-DA; Molecular Probes, Invitrogen) for 30min at
371C. Then, the cells were trypsinized, collectedin ice and acquired by
FACScan. Analysis of ﬂow cytometric data was carried out using
WinMDI software.
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Cell death was estimated using the Apoptosis Detection Kit (Immunolo-
gical Sciences). Cells were plated on coverslips previously treated with
2% gelatin. Cells on coverslips were stained by adding 50mlo fb i n d i n g
buffer, 5mlofA nn e xinV -FIT C,an d5ml ofPI.After15min ofincubationat
371C in the dark, cells were treated with 5mg/ml Hoechst (Invitrogen) for
5min at RT. The cover glasses, mounted in DABCO, were analyzed under
a Nikon ECLIPSE 90i ﬂuorescence microscope equipped with a b/w CCD
camera (Hamamatsu-CoolSNAP, Hamamatsu Corporation Japan), using
Plan Apo objective ( 60 oil; numerical aperture 0.75 and 1.4,
respectively). The images were acquired using the imaging software
Metamorph 7, and then processed in Adobe Photoshop CS3 with
adjustments of brightness and contrast.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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